Citra Borneo Utama Tbk. vs Phapros Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp795 (market cap 2.47T, 58.6K 24h volume), while Phapros Tbk. trades at Rp256 (market cap 211.68B, 116.4K 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 11.7× Phapros Tbk.'s market cap, and Phapros Tbk. is more actively traded (116.4K versus 58.6K). Which is the better fit depends on your goals.
| CBUT | PEHA | |
|---|---|---|
Market Cap | 2.47T | 211.68B |
Volume | 58.6K | 116.4K |
Lot | 586 | 1.16K |
Turnover | 46.6M | 29.27M |
Average Price | 795.15 | 251.47 |
Value | 46.6M | 29.27M |
Indicative Equilibrium Price | 795 | 256 |
Indicative Equilibrium Volume | 1 | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →